Editas Medicine Ownership | Who Owns Editas Medicine?
Editas Medicine Ownership Summary
Editas Medicine is owned by 116.90% institutional investors, 0.20% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 12.07% of EDIT shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.19% of its assets in Editas Medicine shares.
EDIT Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Editas Medicine | 116.90% | 0.20% | -17.10% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 14.40M | 12.07% | $37.01M |
| Tcg crossover management | 11.11M | 11.35% | $36.00M |
| Blackrock | 7.78M | 9.50% | $36.34M |
| Vanguard group | 8.21M | 9.11% | $16.83M |
| Adar1 capital management | 8.89M | 9.08% | $28.80M |
| Commodore capital lp | 8.89M | 9.08% | $28.80M |
| Ra capital management | 8.89M | 9.08% | $28.80M |
| State street | 7.04M | 5.90% | $18.09M |
| Paradigm biocapital advisors lp | 5.59M | 5.71% | $18.10M |
| Vanguard capital management | 6.07M | 5.09% | $15.61M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Commodore capital lp | 8.89M | 1.72% | $28.80M |
| Adar1 capital management | 8.89M | 1.32% | $28.80M |
| Opaleye management | 3.86M | 1.13% | $12.51M |
| Vivo capital | 3.56M | 1.01% | $9.14M |
| Tcg crossover management | 11.11M | 0.87% | $36.00M |
| Highvista strategies | 1.11M | 0.75% | $2.85M |
| Paradigm biocapital advisors lp | 5.59M | 0.34% | $18.10M |
| Logos global management lp | 2.22M | 0.31% | $7.20M |
| Ra capital management | 8.89M | 0.25% | $28.80M |
| Turner financial group | 44.96K | 0.12% | $115.54K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | 11.11M | 0.87% | 11.11M |
| Ra capital management | 8.89M | 0.25% | 8.89M |
| Adar1 capital management | 8.89M | 1.32% | 8.89M |
| Commodore capital lp | 8.89M | 1.72% | 8.89M |
| Paradigm biocapital advisors lp | 5.59M | 0.34% | 5.59M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deep track capital, lp | - | - | -4.90M |
| Avidity partners management lp | - | - | -1.47M |
| Pictet asset management sa | - | - | -1.16M |
| Monaco asset management sam | - | - | -1.07M |
| Mackenzie financial | - | - | -878.04K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Tcg crossover management | 11.11M | 0.87% | 11.11M | $36.00M |
| Adar1 capital management | 8.89M | 1.32% | 8.89M | $28.80M |
| Commodore capital lp | 8.89M | 1.72% | 8.89M | $28.80M |
| Ra capital management | 8.89M | 0.25% | 8.89M | $28.80M |
| Paradigm biocapital advisors lp | 5.59M | 0.34% | 5.59M | $18.10M |
Sold Out
| Holder | Change |
|---|---|
| Gps wealth strategies group | -2.00 |
| Jpl wealth management | -4.00 |
| Pacific capital wealth advisors | -5.00 |
| Sittner & nelson | -6.00 |
| Quintet private bank (europe) | -6.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 228 | - | 139,451,133 | 16.03% | 116 | 1.15% | 107 | -6.14% | 56 | 36.59% |
| Jun 30, 2026 | 221 | 2.79% | 120,168,106 | 131.67% | 122 | 3.59% | 113 | 13.00% | 40 | -14.89% |
| Mar 31, 2026 | 151 | -25.98% | 34,771,706 | -30.36% | 39 | 1.28% | 69 | -8.00% | 27 | -54.24% |
| Dec 31, 2025 | 163 | -20.87% | 39,288,742 | -8.85% | 43 | 1.67% | 54 | -28.00% | 48 | -17.24% |
| Sep 30, 2025 | 197 | - | 43,075,975 | 4.21% | 51 | 2.13% | 69 | -9.21% | 57 | 11.76% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 4.89M | 3.19% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 4.89M | 3.19% | - |
| Vanguard US Total Market Shares ETF | 2.59M | 3.12% | - |
| State Street® SPDR® S&P® Biotech ETF | 4.54M | 2.96% | 118.77K |
| Vanguard MStar Total Stk Mkt Idx Invest | 4.39M | 2.86% | -499.28K |
| iShares Russell 2000 ETF | 3.99M | 2.60% | - |
| Pictet Biopharmaceutical Mother | 1.15M | 1.38% | 42.67K |
| Vanguard Strategic Equity Inv | 2.03M | 1.32% | - |
| Vanguard Small Cap Index | 1.04M | 1.26% | 2.50K |
| Nuveen Quant Small Cap Equity R6 | 1.68M | 1.09% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 11, 2026 | O'Neill Gilmore Neil | CEO | Sell | $51.12K |
| Nov 11, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | $18.87K |
| Sep 03, 2026 | Burkly Linda | EVP, CHIEF SCIENTIFIC OFFICER | Sell | $2.15K |
| Sep 03, 2026 | Parison Amy | SVP, Chief Financial Officer | Sell | $1.38K |
| Sep 03, 2026 | O'Neill Gilmore Neil | CEO | Sell | $15.56K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | 2 |
| 2026 Q3 | - | 5 |
| 2026 Q2 | - | 3 |
| 2026 Q1 | - | 3 |
| 2025 Q4 | - | 3 |
EDIT Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools